A Daily Pill to Treat Covid Could Be Just Months Away, Scientists Say
At least three promising antiviral treatments for covid-19 are being tested in clinical trials, with results expected as soon as late fall or winter.
Covid
461 - 480 of 1,683 Results
-
-
Mounting Covid Deaths Fuel School Bus Drivers’ Fears
Since August, school bus drivers and monitors have died of covid-19 in at least 10 states, including Georgia and Florida. Masks are required on school buses, but enforcing the rules in districts without school mask mandates is especially hard to do.
By Andy Miller and Phil Galewitz -
KHN’s ‘What the Health?’: The Autumn of Democrats’ Discontent
Congress is back in session with a short time to finish a long to-do list, including keeping the government operating and paying its bills. Hanging in the balance is President Joe Biden’s entire domestic agenda, including major changes proposed for Medicare, Medicaid and the Affordable Care Act. Meanwhile, the new Texas abortion law that bans the procedure early in pregnancy is prompting action in Washington. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews former FDA Commissioner Scott Gottlieb about his new book on the covid-19 pandemic.
-
Will ‘Dr. Disinformation’ Ever Face the Music?
Some of the top spreaders of spurious covid-19 and vaccine information are physicians with active medical licenses. Are medical oversight boards ready to step up to stop them?
-
Public Health Experts ‘Flabbergasted’ That Biden Still Hasn’t Picked an FDA Chief
The Food and Drug Administration has been mired in controversies related to drug approvals and covid vaccines, all without a permanent leader.
-
At an Overrun ICU, ‘the Problem Is We Are Running Out of Hallways’
Billings Clinic in Montana is past the tipping point as it looks for places to add intensive care unit beds and is on the cusp of rationing care to deal with the surge of sick covid patients in a state with significant anti-vaccination sentiment.
By Nick Ehli -
Ask KHN-PolitiFact: Is My Cloth Mask Good Enough to Face the Delta Variant?
Public health experts increasingly urge people to upgrade to surgical masks, but also maintain that cloth masks still offer protection.
-
I Got a ‘Mild’ Breakthrough Case. Here’s What I Wish I’d Known.
I was miserable for five days, am fully recovered a month later and have learned even more about what we do and don’t know about covid now.
By Will Stone -
Scientists Examine Kids’ Unique Immune Systems as More Fall Victim to Covid
Doctors are trying to figure out why some kids become much sicker than others and, in rare cases, don’t survive.
By Liz Szabo -
Covid-Overwhelmed Hospitals Postpone Cancer Care and Other Treatment
Patients with advanced cancer and heart disease are among those who have had to have surgeries and other treatments delayed and rescheduled as a high number of critically ill, unvaccinated covid patients strain the medical system.
-
KHN’s ‘What the Health?’: Much Ado About Drug Prices
Democrats have hit a snag in their effort to compile a $3.5 trillion social-spending bill this fall — moderates are resisting support for Medicare drug price negotiation provisions that would pay for many of the measure’s health benefit improvements. Meanwhile, the new abortion restrictions in Texas have moved the divisive issue back to the political front burner. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat and Shefali Luthra of The 19th join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interview’s KHN’s Phil Galewitz about the latest KHN-NPR “Bill of the Month” installment, about two similar jaw surgeries with very different price tags.
-
How Fauci and the NIH Got Ahead of the FDA and CDC in Backing Boosters
With real-time data streaming in from highly specialized researchers in the U.S. and abroad, NIH scientists became convinced that boosting the covid-19 vaccine was needed to save lives, prompting the president to announce a plan with a Sept. 20 start date. Scientists at the regulatory agencies weren’t yet convinced. A meeting Friday will determine what happens next. Here’s the story from behind the scenes.
By Sarah Jane Tribble and Arthur Allen -
When Covid Deaths Are Dismissed or Stigmatized, Grief Is Mixed With Shame and Anger
After their brother died, two sisters faced a barrage of misinformation, pandemic denialism and blaming questions. Grief experts say that makes covid-19 the newest kind of "disenfranchising death."
-
Biden Releases a New Plan to Combat Covid, but Experts Say There’s Still a Ways to Go
There’s agreement that the plan includes important action items but also elements that will trigger political opposition.
By Victoria Knight and Julie Appleby -
Over Half of States Have Rolled Back Public Health Powers in Pandemic
At least 26 states have passed laws to permanently limit public health powers, a KHN investigation has found, weakening the country’s ability to fight not only the current resurgence of the pandemic but other health crises to come.
-
ICUs Are Filled With Covid — And Regret
Unvaccinated people are filling intensive care beds and dying of covid in record numbers in Tennessee and other Southern states. Many tell their nurses and doctors they regret the decision not to get the vaccine when they could.
-
Why At-Home Rapid Covid Tests Cost So Much, Even After Biden’s Push for Lower Prices
Germans pay less than $1 per test. Brits get them free. Why do Americans pay so much more? Because companies can still demand it.
-
Journalists Explain Ramifications of Theranos Trial and Texas’ New Abortion Law
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
-
It’s Not Just Covid: Recall Candidates Represent Markedly Different Choices on Health Care
Those seeking to replace California Gov. Gavin Newsom in Tuesday’s recall election disagree with him on more than mask and vaccine mandates. The conservative candidates tend to favor free-market solutions over Newsom’s expansion of publicly funded health coverage.
By Samantha Young and Rachel Bluth -
ECMO Life Support Is a Last Resort for Covid, and in Short Supply in South
Many more people could benefit from the lifesaving treatment than are receiving it, which has made for messy triaging as the delta variant surges across the South and in rural communities with low covid vaccination rates.